This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pond, C. D. Articles by Barrows, L. R. Search for Related Content PubMed PubMed Citation Articles by Pond, C. D. Articles by Barrows, L. R.

Department of Pharmacology and Toxicology, University of Utah College of Pharmacy, Salt Lake City, Utah

Requests for reprints: Louis R. Barrows, Department of Pharmacology and Toxicology, University of Utah, 30 South 2000 East Room 201, Salt Lake City, UT 84112. Phone: 801-581-4547; Fax: 801-585-5111. E-mail: lbarrows{at}pharm.utah.edu

The topoisomerase I (top1)–targeted camptothecin class of anticancer drugs is important in the treatment of several types of cancers. This class of drug inhibits the top1 enzyme during its catalytic DNA relaxation cycle, stabilizing the transient covalent top1-DNA complex by simultaneous noncovalent interactions with DNA and top1. We examined top1 using phage display because of the significance of this known top1-directed drug action. Several peptides that bind top1 were discovered and these were examined for top1 affinity, top1 catalytic and cleavage complex effects, and cytotoxic effects in cultured cell lines and in an in vivo tumor model. Although several peptides exhibited nanomolar and low-micromolar affinity for top1, none had cytotoxic effects when administered alone. However, in combination with 9-aminocamptothecin, one 15-mer peptide (SAYAATVRGPLSSAS) had synergistic cytotoxic effects with 9-aminocamptothecin both in the cytotoxicity assay and in nude mouse xenograft human tumor models. This report details the investigation of this peptide. [Mol Cancer Ther 2006;5(3):739–45]

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

² www.biosci.missouri.edu:16080/smithgp/

³ http://www.ncbi.nlm.nih.gov/blast

⁴ http://www.expasy.org/sprot

Received 9/20/05; revised 12/ 2/05; accepted 1/11/06.